PMC:7402624 / 40382-40597
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T371","span":{"begin":92,"end":94},"obj":"Body_part"},{"id":"T372","span":{"begin":170,"end":172},"obj":"Body_part"}],"attributes":[{"id":"A371","pred":"fma_id","subj":"T371","obj":"http://purl.org/sig/ont/fma/fma84371"},{"id":"A372","pred":"fma_id","subj":"T372","obj":"http://purl.org/sig/ont/fma/fma84371"}],"text":"Examining categorical rather than continuous clinical data, 80% of patients with decreasing PB over time had hyperlipidemia, whereas only 20% of patients with increasing PB over time had this comorbidity (fig. S6D)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1435","span":{"begin":67,"end":75},"obj":"Species"},{"id":"1436","span":{"begin":145,"end":153},"obj":"Species"},{"id":"1445","span":{"begin":92,"end":94},"obj":"Chemical"},{"id":"1446","span":{"begin":170,"end":172},"obj":"Chemical"},{"id":"1454","span":{"begin":109,"end":123},"obj":"Disease"}],"attributes":[{"id":"A1435","pred":"tao:has_database_id","subj":"1435","obj":"Tax:9606"},{"id":"A1436","pred":"tao:has_database_id","subj":"1436","obj":"Tax:9606"},{"id":"A1454","pred":"tao:has_database_id","subj":"1454","obj":"MESH:D006949"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Examining categorical rather than continuous clinical data, 80% of patients with decreasing PB over time had hyperlipidemia, whereas only 20% of patients with increasing PB over time had this comorbidity (fig. S6D)."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T311","span":{"begin":92,"end":94},"obj":"Disease"},{"id":"T312","span":{"begin":109,"end":123},"obj":"Disease"},{"id":"T313","span":{"begin":170,"end":172},"obj":"Disease"}],"attributes":[{"id":"A311","pred":"mondo_id","subj":"T311","obj":"http://purl.obolibrary.org/obo/MONDO_0019035"},{"id":"A312","pred":"mondo_id","subj":"T312","obj":"http://purl.obolibrary.org/obo/MONDO_0021187"},{"id":"A313","pred":"mondo_id","subj":"T313","obj":"http://purl.obolibrary.org/obo/MONDO_0019035"}],"text":"Examining categorical rather than continuous clinical data, 80% of patients with decreasing PB over time had hyperlipidemia, whereas only 20% of patients with increasing PB over time had this comorbidity (fig. S6D)."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T278","span":{"begin":92,"end":94},"obj":"Chemical"},{"id":"T280","span":{"begin":170,"end":172},"obj":"Chemical"}],"attributes":[{"id":"A278","pred":"chebi_id","subj":"T278","obj":"http://purl.obolibrary.org/obo/CHEBI_53319"},{"id":"A279","pred":"chebi_id","subj":"T278","obj":"http://purl.obolibrary.org/obo/CHEBI_60686"},{"id":"A280","pred":"chebi_id","subj":"T280","obj":"http://purl.obolibrary.org/obo/CHEBI_53319"},{"id":"A281","pred":"chebi_id","subj":"T280","obj":"http://purl.obolibrary.org/obo/CHEBI_60686"}],"text":"Examining categorical rather than continuous clinical data, 80% of patients with decreasing PB over time had hyperlipidemia, whereas only 20% of patients with increasing PB over time had this comorbidity (fig. S6D)."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T12","span":{"begin":109,"end":123},"obj":"Phenotype"}],"attributes":[{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0003077"}],"text":"Examining categorical rather than continuous clinical data, 80% of patients with decreasing PB over time had hyperlipidemia, whereas only 20% of patients with increasing PB over time had this comorbidity (fig. S6D)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T234","span":{"begin":0,"end":215},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Examining categorical rather than continuous clinical data, 80% of patients with decreasing PB over time had hyperlipidemia, whereas only 20% of patients with increasing PB over time had this comorbidity (fig. S6D)."}